The angiogenesis inhibitor TNP-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease

Clinical Cancer Research

Volumn 7, Issue 4, 2001, Pages 977-984

  Shusterman, S ^a   Grupp, S A ^a   Barr, R ^a   Carpentieri, D ^a   Zhao, H ^a   Maris, J M ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CELL DIVISION; CYCLOHEXANES; HUMANS; MICE; MICE, NUDE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROBLASTOMA; SESQUITERPENES; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034906623     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Molecular biology of neuroblastomas
2. Neuroblastoma
3. Neuroblastoma: Biology and therapy
4. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
5. Neuroblastoma and treatment-related myelodysplasia/leukemia: The memorial Sloan-Kettering experience and a literature review
6. Tumor angiogenesis correlates with metastatic disease. N-Myc amplification, and poor outcome in human neuroblastoma
7. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2
8. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth
9. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo
10. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines
11. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats
12. Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma
13. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma
14. A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix
15. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden
16. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
17. Development of a murine gastric distension model for testing the emetic potential of new drugs and efficacy of antiemetics
18. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
19. Establishment and characterization of human neuroblastoma cell lines
20. Determination of subcutaneous tumor size in athymic (nude) mice
21. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
22. Angiostatin induces and sustains dormancy of human primary tumors in mice
23. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
24. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
25. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
26. Integrins α (v) β3 and α (v) β5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide
27. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas
28. Angiogenesis in cancer, vascular, rheumatoid, and other diseases
29. A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer